The above chart presents the market trend analysis for astellas pharmaceuticals pvt from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 10 transactions, with a transaction quantity of 55043.5 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025441899210
20261055043.50
Bill of lading data
<
1/15
>
Trade date
2026/06/24
B/L No.
——
Suppliers
sinopharma weiqida pharmaceuti china
Buyers
astellas pharmaceuticals pvt
POLs
——
PODs
kpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
7519.996404
Hs code
29419090
Product tags
pharmaceutical raw material,ceftriaxone sodium sterile
Product description
(PHARMACEUTICAL RAW MATERIAL) CEFTRIAXONE SODIUM STERILE USP
Expand
Trade date
2026/05/21
B/L No.
——
Suppliers
shandong pharmaceutical glass co ltd
Buyers
astellas pharmaceuticals pvt
astellas pharmaceuticals pvt is pakistan Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceuticals raw material,pc,pharmaceutical raw material.
According to the 52wmb.com global trade database, as of 2026-06-24, the company has completed 499 international trades,
with its main trading regions covering other,china,costa rica etc.
The core products include HS29419090,HS70109000,HS40169990 etc,
often transported via karachi air freight unit,port ppaf, port kpaf etc,
and its main trading partners are jiangyin sunway international,sinopharma weiqida pharmaceuti china,lizhu pharmaceuitical trading co.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on astellas pharmaceuticals pvt is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.